Giandomenico Bisaccia, MD, PhD

281 posts

Giandomenico Bisaccia, MD, PhD banner
Giandomenico Bisaccia, MD, PhD

Giandomenico Bisaccia, MD, PhD

@bisacciaMD

MSc student @LSEHealthPolicy | MD-PhD @UnivUda | #WhyCMR fellow @RBandH

Katılım Mayıs 2019
685 Takip Edilen210 Takipçiler
Cristian Topriceanu
Cristian Topriceanu@CTopriceanu·
Thrilled to have won the @BSCMR young investigator award! This would not have been possible without @gabycaptur from @UCL_ICS/@MRCLHA and prof. Anna Hansell from @uniofleicester. Congratulations to all the finalists for their impactful work and excellent presentations.
Gabriella Captur@gabycaptur

🏆🍾🥇The amazing Dr Cristian Topriceanu @UCL_ICS wins @BSCMR Young Investigator Award showing how aircraft noise pollution✈️impacts the human heart🫀🧲 Thank you @BSCMR and well done to the other excellent finalists👏 @CTopriceanu

English
6
5
28
2.1K
Giandomenico Bisaccia, MD, PhD retweetledi
Anna Giulia Pavon
Anna Giulia Pavon@AnnaGiuliaPavon·
🧲 SAVE THE Date 🎉🎉 #scmr25 will take place in Washington 29.01-1.02 👉 Be parte of it: abstract submission closing on the 5th sept! @SCMRorg @MRI_CPrieto Clerio Azvedo Brian Allen Michael Markl @chiarabd @vineetao17
Anna Giulia Pavon tweet media
English
1
13
25
1.2K
Giandomenico Bisaccia, MD, PhD
Giandomenico Bisaccia, MD, PhD@bisacciaMD·
Heart transplant recipients deserve the diagnostic precision of quantitative #stressCMR Read our latest research on EHJ Cardiovascular Imaging academic.oup.com/ehjcimaging/ad… @chiarabd @fabrizioricci @giulialavecchi3
Henry Han@HanCardiomd

Safety and feasibility of adenosine stress cardiac MRI in heart transplant recipients academic.oup.com/ehjcimaging/ad… #EHJCVI @chiarabd #WhyCMR @GeraldMaurer @alessia_gimelli @Sarah_Moharem @vass_vassiliou @AnnaKateBarton

English
1
2
8
867
Giandomenico Bisaccia, MD, PhD
Giandomenico Bisaccia, MD, PhD@bisacciaMD·
Super proud of having done PhD work @RBandH with you @chiarabd! And special thanks to my fellow colleagues incl @giulialavecchi3 More to come from our Harefield team 😉
C Bucciarelli-Ducci@chiarabd

Thank you @HanCardiomd for showcasing our research! 🙏 Great work from @bisacciaMD and all my team at #HarefieldHospital @RBandH #whyCMR ❤️ adenosine: safe stressor post heart transplant ❤️quantitive stress CMR ⬆️ value vs visual to predict CAV (cardiac allograft vasculopathy)

English
0
0
2
88
Giandomenico Bisaccia, MD, PhD retweetledi
Frank Harrell
Frank Harrell@f2harrell·
@drjohnm And how can we applaud a study that published an analysis that is not consistent with the parallel-group design and didn't recognize serious problems with change from baseline?
English
2
2
19
4.3K
Giandomenico Bisaccia, MD, PhD retweetledi
Venk Murthy MD PhD
Venk Murthy MD PhD@venkmurthy·
I'm always hesitant to use use terms like game changer, but these are the three trials that could have the greatest impact on practice of cardiology, depending on results. Nice summary by @drjohnm sensible-med.com/p/modern-cardi…
English
4
13
39
7.6K
Giandomenico Bisaccia, MD, PhD retweetledi
C Bucciarelli-Ducci
C Bucciarelli-Ducci@chiarabd·
Congrats to @bisacciaMD for very capably defending his PhD thesis and work done at @RBandH. Thank you to external examiner @rmanka_ ! Very proud of you Giando, you are a very bright 🌟 and talented young colleague! I am looking forward to the many successes awaiting you!🤩
C Bucciarelli-Ducci tweet mediaC Bucciarelli-Ducci tweet mediaC Bucciarelli-Ducci tweet media
English
3
1
5
650
Giandomenico Bisaccia, MD, PhD
Giandomenico Bisaccia, MD, PhD@bisacciaMD·
@drgocchipinti Thanks for sharing, very interesting. I wonder whether an effect on CV events would be proven specifically due to such liver fat reduction (i.e. vs patients w/ comparable CV risk and no MASLD) or would aspirin just work as expected. Thoughts?
English
0
0
0
62
Giovanni Occhipinti
Giovanni Occhipinti@drgocchipinti·
In the context of a progressive attempt to shift away from #aspirin in anti-thrombotic therapy, a preliminary RCT of 80 MASLD patients found that 6 months of daily low-dose aspirin significantly reduced hepatic fat measured by MRS (-6.6%; p=0.09) compared to placebo.
Giovanni Occhipinti tweet media
English
2
0
1
235
Paolo Crosetto
Paolo Crosetto@PaoloCrosetto·
@giandomd @danbrockington @pagomba More journals are there than people think, they are just "hidden" because of the naming convention/shortening. For instance Journal of Clinical Medicine (MDPI) is there, under an abbreviated name "J. Clin. Med.". We will try to find a way to make search more intelligent...
Paolo Crosetto tweet media
English
1
0
1
123
Dan Brockington
Dan Brockington@danbrockington·
Anyone struggling to navigate academic publishing must see this fantastic resource, courtesy of the amazing @PaoloCrosetto @pagomba & Mark Hanson. Makes key metrics easily accessible - still in development, comments welcome. Builds off our 'Strain' paper shorturl.at/kmsOQ
Paolo Crosetto@PaoloCrosetto

About to publish in a scientific journal? Want to know more about specific publishers? We released The Strain Explorer, where you find data on Turnaround times, output, shares of special issues, and impact factor inflation. Here: pagoba.shinyapps.io/strain_explore… Read along for a 🧵

English
1
6
15
1.8K
Vinay Prasad MD MPH
Vinay Prasad MD MPH@VPrasadMDMPH·
To current screening with some other advantage Merely documenting the sensitivity and specificity of a novel test is nearly pointless. You have no idea how its impact will be in the real world. You don't know it will reduce colorectal cancer death
English
2
1
8
1.2K
Vinay Prasad MD MPH
Vinay Prasad MD MPH@VPrasadMDMPH·
We have randomized data for FOBT and Fit leverages these data. So what should be the bar for new colorectal cancer test? Obviously randomized control trial data showing that it lowers the risk of colorectal cancer death in addition to current screening, or is non-inferior
English
1
2
13
7.1K

Keşfet

@CTopriceanu @BSCMR @gabycaptur @UCL_ICS @MRCLHA @uniofleicester @SCMRorg @MRI_CPrieto